Mandate

Vinge advises Flower in connection with the acquisition of the Pajkölen battery storage project

Vinge has advised the energy technology company Flower Infrastructure Technologies AB (“Flower”) in the acquisition of one of Sweden's largest battery storage projects, Pajkölen, from Arise AB (publ) (“Arise”). The project, which is a 40 MW / 80 MWh Ready-to-Build battery energy storage system (BESS), is located in the Kölvallen wind farm in Ljusdal municipality. The transaction comprise all shares in Pajkölen BESS AB, which owns all rights to the project.

Closing is subject to e.g. certain regulatory approvals and is expected to take place in the fourth quarter of 2024, with grid connection expected to be completed in the first half of 2025.

Through the acquisition, Flower strengthens its position as the country's leading actor in battery optimisation. Once the project is operational, Flower will have complete control over the entire battery value chain, opening up important revenue streams for renewable energy actors, such as grid operators or owners of renewable power.

Vinge's team consisted mainly of Peter Sundgren, Niklas Suni and Gustav Wahlberg (M&A), Kristoffer Larson (Real Estate and Construction), Lina Österberg (Environment), Carla Zachariasson and Ian Linde (Commercial Agreements) and Daniel Wendelsson, Dagne Sabockis and Alva Chambert (FDI).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026